Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 69


Low-dose oral theophylline combined with inhaled corticosteroids for people with chronic obstructive pulmonary disease and high risk of exacerbations: a RCT.

Devereux G, Cotton S, Fielding S, McMeekin N, Barnes PJ, Briggs A, Burns G, Chaudhuri R, Chrystyn H, Davies L, Soyza A, Gompertz S, Haughney J, Innes K, Kaniewska J, Lee A, Morice A, Norrie J, Sullivan A, Wilson A, Price D.

Health Technol Assess. 2019 Jul;23(37):1-146. doi: 10.3310/hta23370.


Scottish consensus statement on the role of FeNO in adult asthma.

Kuo CR, Spears M, Haughney J, Smith A, Miller J, Bradshaw T, Murray L, Williamson P, Lipworth B.

Respir Med. 2019 Aug;155:54-57. doi: 10.1016/j.rmed.2019.07.010. Epub 2019 Jul 6. Review.


Comparison of adverse events associated with different spacers used with non-extrafine beclometasone dipropionate for asthma.

Ming SWY, Haughney J, Ryan D, Patel S, Ochel M, d'Alcontres MS, Thornhill S, Kocks JWH, Price D.

NPJ Prim Care Respir Med. 2019 Feb 8;29(1):3. doi: 10.1038/s41533-019-0115-0.


Cost-effectiveness of physical activity in the management of COPD patients in the UK.

Ramos M, Lamotte M, Gerlier L, Svangren P, Miquel-Cases A, Haughney J.

Int J Chron Obstruct Pulmon Dis. 2019 Jan 15;14:227-239. doi: 10.2147/COPD.S181194. eCollection 2019.


Effect of Theophylline as Adjunct to Inhaled Corticosteroids on Exacerbations in Patients With COPD: A Randomized Clinical Trial.

Devereux G, Cotton S, Fielding S, McMeekin N, Barnes PJ, Briggs A, Burns G, Chaudhuri R, Chrystyn H, Davies L, De Soyza A, Gompertz S, Haughney J, Innes K, Kaniewska J, Lee A, Morice A, Norrie J, Sullivan A, Wilson A, Price D.

JAMA. 2018 Oct 16;320(15):1548-1559. doi: 10.1001/jama.2018.14432.


A review of asthma care in 50 general practices in Bedfordshire, United Kingdom.

Levy ML, Garnett F, Kuku A, Pertsovskaya I, McKnight E, Haughney J.

NPJ Prim Care Respir Med. 2018 Jul 26;28(1):29. doi: 10.1038/s41533-018-0093-7.


A retrospective cohort study in severe asthma describing commonly measured biomarkers: Eosinophil count and IgE levels.

Haughney J, Morice A, Blyth KG, Lee AJ, Coutts A, McKnight E, Pavord I.

Respir Med. 2018 Jan;134:117-123. doi: 10.1016/j.rmed.2017.12.001. Epub 2017 Dec 5.


Continuing Trauma: The Unmet Needs of Trauma Patients in the Postacute Care Setting.

Fakhry SM, Ferguson PL, Olsen JL, Haughney JJ, Resnick HS, Ruggiero KJ.

Am Surg. 2017 Nov 1;83(11):1308-1314.


Initiating or changing to a fixed-dose combination of Fluticasone propionate/Formoterol over Fluticasone propionate/Salmeterol: A real-life effectiveness and cost impact evaluation.

Wan Yau Ming S, Haughney J, Small I, Wolfe S, Hamill J, Gruffydd-Jones K, Daly C, Soriano JB, Gardener E, Skinner D, Stagno d'Alcontres M, Price DB.

Respir Med. 2017 Aug;129:199-206. doi: 10.1016/j.rmed.2017.06.016. Epub 2017 Jun 24.


Inhaler Errors in the CRITIKAL Study: Type, Frequency, and Association with Asthma Outcomes.

Price DB, Román-Rodríguez M, McQueen RB, Bosnic-Anticevich S, Carter V, Gruffydd-Jones K, Haughney J, Henrichsen S, Hutton C, Infantino A, Lavorini F, Law LM, Lisspers K, Papi A, Ryan D, Ställberg B, van der Molen T, Chrystyn H.

J Allergy Clin Immunol Pract. 2017 Jul - Aug;5(4):1071-1081.e9. doi: 10.1016/j.jaip.2017.01.004. Epub 2017 Mar 9.


Cohort profile: the Scottish Research register SHARE. A register of people interested in research participation linked to NHS data sets.

McKinstry B, Sullivan FM, Vasishta S, Armstrong R, Hanley J, Haughney J, Philip S, Smith BH, Wood A, Palmer CN.

BMJ Open. 2017 Feb 1;7(2):e013351. doi: 10.1136/bmjopen-2016-013351.


First maintenance therapy for COPD in the UK between 2009 and 2012: a retrospective database analysis.

Price D, Miravitlles M, Pavord I, Thomas M, Wedzicha J, Haughney J, Bichel K, West D.

NPJ Prim Care Respir Med. 2016 Nov 3;26:16061. doi: 10.1038/npjpcrm.2016.61.


Core requirements for successful data linkage: an example of a triangulation method.

Hopf YM, Francis J, Helms PJ, Haughney J, Bond C.

BMJ Open. 2016 Oct 21;6(10):e011879. doi: 10.1136/bmjopen-2016-011879.


Cost versus utility of aclidinium bromide 400 µg plus formoterol fumarate dihydrate 12 µg compared to aclidinium bromide 400 µg alone in the management of moderate-to-severe COPD.

Ramos M, Haughney J, Henry N, Lindner L, Lamotte M.

Clinicoecon Outcomes Res. 2016 Sep 12;8:445-56. doi: 10.2147/CEOR.S107121. eCollection 2016.


Metabolic Effects Associated with ICS in Patients with COPD and Comorbid Type 2 Diabetes: A Historical Matched Cohort Study.

Price DB, Russell R, Mares R, Burden A, Skinner D, Mikkelsen H, Ding C, Brice R, Chavannes NH, Kocks JW, Stephens JW, Haughney J.

PLoS One. 2016 Sep 22;11(9):e0162903. doi: 10.1371/journal.pone.0162903. eCollection 2016.


Assessing Asthma Symptoms in Adolescents and Adults: Qualitative Research Supporting Development of the Asthma Daily Symptom Diary.

Gater A, Nelsen L, Fleming S, Lundy JJ, Bonner N, Hall R, Marshall C, Staunton H, Krishnan JA, Stoloff S, Schatz M, Haughney J; Patient-Reported Outcome Consortium’s Asthma Working Group.

Value Health. 2016 Jun;19(4):440-50. doi: 10.1016/j.jval.2016.01.007. Epub 2016 Mar 30.


Characteristics of patients making serious inhaler errors with a dry powder inhaler and association with asthma-related events in a primary care setting.

Westerik JA, Carter V, Chrystyn H, Burden A, Thompson SL, Ryan D, Gruffydd-Jones K, Haughney J, Roche N, Lavorini F, Papi A, Infantino A, Roman-Rodriguez M, Bosnic-Anticevich S, Lisspers K, Ställberg B, Henrichsen SH, van der Molen T, Hutton C, Price DB.

J Asthma. 2016;53(3):321-9. doi: 10.3109/02770903.2015.1099160. Epub 2016 Jan 26.


Comparison of serious inhaler technique errors made by device-naïve patients using three different dry powder inhalers: a randomised, crossover, open-label study.

Chrystyn H, Price DB, Molimard M, Haughney J, Bosnic-Anticevich S, Lavorini F, Efthimiou J, Shan D, Sims E, Burden A, Hutton C, Roche N.

BMC Pulm Med. 2016 Jan 14;16:12. doi: 10.1186/s12890-016-0169-5.


Linking NHS data for pediatric pharmacovigilance: Results of a Delphi survey.

Hopf YM, Francis J, Helms PJ, Haughney J, Bond C.

Res Social Adm Pharm. 2016 Mar-Apr;12(2):267-80. doi: 10.1016/j.sapharm.2015.06.006. Epub 2015 Jul 2.


Use of low-dose oral theophylline as an adjunct to inhaled corticosteroids in preventing exacerbations of chronic obstructive pulmonary disease: study protocol for a randomised controlled trial.

Devereux G, Cotton S, Barnes P, Briggs A, Burns G, Chaudhuri R, Chrystyn H, Davies L, De Soyza A, Fielding S, Gompertz S, Haughney J, Lee AJ, McCormack K, McPherson G, Morice A, Norrie J, Sullivan A, Wilson A, Price D.

Trials. 2015 Jun 10;16:267. doi: 10.1186/s13063-015-0782-2.


Preference, satisfaction and critical errors with Genuair and Breezhaler inhalers in patients with COPD: a randomised, cross-over, multicentre study.

Pascual S, Feimer J, De Soyza A, Sauleda Roig J, Haughney J, Padullés L, Seoane B, Rekeda L, Ribera A, Chrystyn H.

NPJ Prim Care Respir Med. 2015 Apr 30;25:15018. doi: 10.1038/npjpcrm.2015.18.


Serum periostin in smokers and never smokers with asthma.

Thomson NC, Chaudhuri R, Spears M, Haughney J, McSharry C.

Respir Med. 2015 Jun;109(6):708-15. doi: 10.1016/j.rmed.2015.03.009. Epub 2015 Apr 3.


Characterisation of the frequent exacerbator phenotype in COPD patients in a large UK primary care population.

McGarvey L, Lee AJ, Roberts J, Gruffydd-Jones K, McKnight E, Haughney J.

Respir Med. 2015 Feb;109(2):228-37. doi: 10.1016/j.rmed.2014.12.006. Epub 2014 Dec 30.


'The more you link, the more you risk …' - a focus group study exploring views about data linkage for pharmacovigilance.

Hopf YM, Bond C, Francis J, Haughney J, Helms PJ.

Br J Clin Pharmacol. 2014 Nov;78(5):1143-50. doi: 10.1111/bcp.12445.


Case-finding of chronic obstructive pulmonary disease with questionnaire, peak flow measurements and spirometry: a cross-sectional study.

Mahboub B, Alzaabi A, Soriano JB, Salameh L, Mutairi YA, Yusufali AA, Alsheikh-ali A, Almahmeed W, Haughney J.

BMC Res Notes. 2014 Apr 16;7:241. doi: 10.1186/1756-0500-7-241.


Guidance on handheld inhalers in asthma and COPD guidelines.

Dekhuijzen PN, Bjermer L, Lavorini F, Ninane V, Molimard M, Haughney J.

Respir Med. 2014 May;108(5):694-700. doi: 10.1016/j.rmed.2014.02.013. Epub 2014 Mar 1. Review.


Linked health data for pharmacovigilance in children: perceived legal and ethical issues for stakeholders and data guardians.

Hopf YM, Bond CB, Francis JJ, Haughney J, Helms PJ.

BMJ Open. 2014 Feb 12;4(2):e003875. doi: 10.1136/bmjopen-2013-003875.


Switching from branded to generic inhaled medications: potential impact on asthma and COPD.

Lavorini F, Ninane V, Haughney J, Bjermer L, Molimard M, Dekhuijzen RP.

Expert Opin Drug Deliv. 2013 Dec;10(12):1597-602. doi: 10.1517/17425247.2013.852182. Epub 2013 Nov 14.


Clinical and cost effectiveness of switching asthma patients from fluticasone-salmeterol to extra-fine particle beclometasone-formoterol: a retrospective matched observational study of real-world patients.

Price D, Small I, Haughney J, Ryan D, Gruffydd-Jones K, Lavorini F, Harris T, Burden A, Brockman J, King C, Papi A.

Prim Care Respir J. 2013 Dec;22(4):439-48. doi: 10.4104/pcrj.2013.00088.


The distribution of COPD in UK general practice using the new GOLD classification.

Haughney J, Gruffydd-Jones K, Roberts J, Lee AJ, Hardwell A, McGarvey L.

Eur Respir J. 2014 Apr;43(4):993-1002. doi: 10.1183/09031936.00065013. Epub 2013 Oct 31.


Views of healthcare professionals to linkage of routinely collected healthcare data: a systematic literature review.

Hopf YM, Bond C, Francis J, Haughney J, Helms PJ.

J Am Med Inform Assoc. 2014 Feb;21(e1):e6-10. doi: 10.1136/amiajnl-2012-001575. Epub 2013 May 28. Review.


Real-life comparison of beclometasone dipropionate as an extrafine- or larger-particle formulation for asthma.

Price D, Thomas M, Haughney J, Lewis RA, Burden A, von Ziegenweidt J, Chisholm A, Hillyer EV, Corrigan CJ.

Respir Med. 2013 Jul;107(7):987-1000. doi: 10.1016/j.rmed.2013.03.009. Epub 2013 May 3.


Prevalence of common chronic respiratory diseases in drug misusers: a cohort study.

Palmer F, Jaffray M, Moffat MA, Matheson C, McLernon DJ, Coutts A, Haughney J.

Prim Care Respir J. 2012 Dec;21(4):377-83. doi: 10.4104/pcrj.2012.00069.


Effectiveness of same versus mixed asthma inhaler devices: a retrospective observational study in primary care.

Price D, Chrystyn H, Kaplan A, Haughney J, Román-Rodríguez M, Burden A, Chisholm A, Hillyer EV, von Ziegenweidt J, Ali M, van der Molen T.

Allergy Asthma Immunol Res. 2012 Jul;4(4):184-91. doi: 10.4168/aair.2012.4.4.184. Epub 2012 Apr 6.


Do asthmatic smokers benefit as much as non-smokers on budesonide/formoterol maintenance and reliever therapy? Results of an open label study.

van Schayck OC, Haughney J, Aubier M, Selroos O, Ekström T, Ostinelli J, Buhl R.

Respir Med. 2012 Feb;106(2):189-96. doi: 10.1016/j.rmed.2011.10.017. Epub 2011 Nov 26.


Inhaled corticosteroid/long-acting β₂-agonist combination therapy for asthma: attitudes of specialists in Europe.

Bousquet J, Winchester C, Papi A, Virchow JC, Haughney J, Costa D, Usmani O, Bjermer L, Price D; Global Allergy and Asthma European Network (GA²LEN).

Int Arch Allergy Immunol. 2012;157(3):303-10. doi: 10.1159/000329519. Epub 2011 Nov 1.


Current control and future risk in asthma management.

Sims EJ, Price D, Haughney J, Ryan D, Thomas M.

Allergy Asthma Immunol Res. 2011 Oct;3(4):217-25. doi: 10.4168/aair.2011.3.4.217. Epub 2011 Sep 21.


Effectiveness of inhaler types for real-world asthma management: retrospective observational study using the GPRD.

Price D, Haughney J, Sims E, Ali M, von Ziegenweidt J, Hillyer EV, Lee AJ, Chisholm A, Barnes N.

J Asthma Allergy. 2011;4:37-47. doi: 10.2147/JAA.S17709. Epub 2011 Apr 28.


Is the patient's baseline inhaled steroid dose a factor for choosing the budesonide/formoterol maintenance and reliever therapy regimen?

Aubier M, Haughney J, Selroos O, van Schayck OC, Ekström T, Ostinelli J, Buhl R.

Ther Adv Respir Dis. 2011 Oct;5(5):289-98. doi: 10.1177/1753465811407236. Epub 2011 May 17. Erratum in: Ther Adv Respir Dis. 2012 Aug;6(4):247.


Inhaler devices for asthma: a call for action in a neglected field.

Papi A, Haughney J, Virchow JC, Roche N, Palkonen S, Price D.

Eur Respir J. 2011 May;37(5):982-5. doi: 10.1183/09031936.00150910. No abstract available.


Comparing asthma treatment in elderly versus younger patients.

Haughney J, Aubier M, Jørgensen L, Ostinelli J, Selroos O, van Schayck CP, Buhl R.

Respir Med. 2011 Jun;105(6):838-45. doi: 10.1016/j.rmed.2011.02.011. Epub 2011 Mar 23.


Who should look after children with asthma?

Haughney J.

Prim Care Respir J. 2011 Mar;20(1):9-10. doi: 10.4104/pcrj.2011.00014. No abstract available.


Development and implementation of guidelines in allergic rhinitis – an ARIA-GA2LEN paper.

Bousquet J, Schünemann HJ, Zuberbier T, Bachert C, Baena-Cagnani CE, Bousquet PJ, Brozek J, Canonica GW, Casale TB, Demoly P, Gerth van Wijk R, Ohta K, Bateman ED, Calderon M, Cruz AA, Dolen WK, Haughney J, Lockey RF, Lötvall J, O'Byrne P, Spranger O, Togias A, Bonini S, Boulet LP, Camargos P, Carlsen KH, Chavannes NH, Delgado L, Durham SR, Fokkens WJ, Fonseca J, Haahtela T, Kalayci O, Kowalski ML, Larenas-Linnemann D, Li J, Mohammad Y, Mullol J, Naclerio R, O'Hehir RE, Papadopoulos N, Passalacqua G, Rabe KF, Pawankar R, Ryan D, Samolinski B, Simons FE, Valovirta E, Yorgancioglu A, Yusuf OM, Agache I, Aït-Khaled N, Annesi-Maesano I, Beghe B, Ben Kheder A, Blaiss MS, Boakye DA, Bouchard J, Burney PG, Busse WW, Chan-Yeung M, Chen Y, Chuchalin AG, Costa DJ, Custovic A, Dahl R, Denburg J, Douagui H, Emuzyte R, Grouse L, Humbert M, Jackson C, Johnston SL, Kaliner MA, Keith PK, Kim YY, Klossek JM, Kuna P, Le LT, Lemiere C, Lipworth B, Mahboub B, Malo JL, Marshall GD, Mavale-Manuel S, Meltzer EO, Morais-Almeida M, Motala C, Naspitz C, Nekam K, Niggemann B, Nizankowska-Mogilnicka E, Okamoto Y, Orru MP, Ouedraogo S, Palkonen S, Popov TA, Price D, Rosado-Pinto J, Scadding GK, Sooronbaev TM, Stoloff SW, Toskala E, van Cauwenberge P, Vandenplas O, van Weel C, Viegi G, Virchow JC, Wang DY, Wickman M, Williams D, Yawn BP, Zar HJ, Zernotti M, Zhong N; WHO Collaborating Center of Asthma and Rhinitis (Montpellier).

Allergy. 2010 Oct;65(10):1212-21. doi: 10.1111/j.1398-9995.2010.02480.x.


Comparison of two twice-daily doses of budesonide/formoterol maintenance and reliever therapy.

Aubier M, Buhl R, Ekström T, Ostinelli J, van Schayck CP, Selroos O, Haughney J.

Eur Respir J. 2010 Sep;36(3):524-30. doi: 10.1183/09031936.00022010. Epub 2010 Jul 1.


Choosing inhaler devices for people with asthma: current knowledge and outstanding research needs.

Haughney J, Price D, Barnes NC, Virchow JC, Roche N, Chrystyn H.

Respir Med. 2010 Sep;104(9):1237-45. doi: 10.1016/j.rmed.2010.04.012. Epub 2010 May 15. Review.


Improving clinician-patient communication in asthma: the HARP project.

Haughney J, Sims E, Holohan J, Ryan D, Price D.

Allergy. 2010 Apr;65(4):413-4. doi: 10.1111/j.1398-9995.2009.02127.x. Epub 2010 Feb 8. No abstract available.


Cost-effectiveness analysis of corticosteroid inhaler devices in primary care asthma management: A real world observational study.

Kemp L, Haughney J, Barnes N, Sims E, von Ziegenweidt J, Hillyer EV, Lee AJ, Chisholm A, Price D.

Clinicoecon Outcomes Res. 2010;2:75-85. Epub 2010 Jul 1.


The value of self-report assessment of adherence, rhinitis and smoking in relation to asthma control.

Clatworthy J, Price D, Ryan D, Haughney J, Horne R.

Prim Care Respir J. 2009 Dec;18(4):300-5. doi: 10.4104/pcrj.2009.00037.


Driving asthma care in Europe: the Brussels Declaration.

Haughney J, Palkonen S, Price D, Thomas M, Holgate S.

Prim Care Respir J. 2009 Jun;18(2):55-6. doi: 10.4104/pcrj.2009.00015. No abstract available.

Supplemental Content

Loading ...
Support Center